Latest News

Postinfectious Cough: Are Treatments Ever Warranted?


 

FROM THE CANADIAN MEDICAL ASSOCIATION JOURNAL

Environmental Concerns

Yet some things should raise clinicians’ suspicion of more complex issues.

“A pattern of recurrent colds or bronchitis with protracted coughing afterward raises strong suspicion for asthma, which can present as repeated, prolonged respiratory exacerbations,” he said. “Unless asthma is treated with appropriate inhaler therapy on a regular basis, it will unlikely come under control.”

Dr. Vozoris added that the environmental concerns over the use of metered dose inhalers (MDIs) are minimal compared with the other sources of pollution and the risks for undertreatment. “The authors are overplaying the environmental impact of MDI, in my opinion,” he said. “Physicians already have to deal with the challenging issue of suboptimal patient adherence to inhalers, and I fear that such comments may further drive that up. Furthermore, there is also an environmental footprint with not using inhalers, as patients can then experience suboptimally controlled lung disease as a result — and then present to the ER and get admitted to hospital for exacerbations of disease, where more resources and medications are used up.”

“In addition, in patients who are immunocompromised, protracted coughing after what was thought to be a cold may be associated with an “atypical” respiratory infection, such as tuberculosis, that will require special medical treatment,” Dr. Vozoris concluded.

No funding for the review of postinfectious cough was reported. Dr. Liang and Dr. Vozoris disclosed no competing interests. Dr. Satia reported receiving funding from the ERS Respire 3 Fellowship Award, BMA James Trust Award, North-West Lung Centre Charity (Manchester), NIHR CRF Manchester, Merck MSD, AstraZeneca, and GSK. Dr. Satia also has received consulting fees from Merck MSD, Genentech, and Respiplus; as well as speaker fees from AstraZeneca, GSK, Merck MSD, Sanofi-Regeneron. Satia has served on the following task force committees: Chronic Cough (ERS), Asthma Diagnosis and Management (ERS), NEUROCOUGH (ERS CRC), and the CTS Chronic Cough working group.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Factors linked with increased VTE risk in COVID outpatients
Federal Practitioner
NOVIDs: Do some have the genes to dodge COVID?
Federal Practitioner
COVID can mimic prostate cancer symptoms
Federal Practitioner
Tyrosine kinase inhibitors – a new weapon against respiratory viruses?
Federal Practitioner
New drugs in primary care: Lessons learned from COVID-19
Federal Practitioner
Proteomics reveals potential targets for drug-resistant TB
Federal Practitioner
Comorbid respiratory disease key predictor of NTM-PD
Federal Practitioner
Neutropenia affects clinical presentation of pulmonary mucormycosis
Federal Practitioner
Intense exercise may lead to colds. A new study tells us why
Federal Practitioner
Respiratory Virus Surge: Diagnosing COVID-19 vs RSV, Flu
Federal Practitioner